ClinicalTrials.gov
ClinicalTrials.gov Menu

Title XELOX FOR SALIVARY GLAND CANCERS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00101075
Recruitment Status : Terminated (Slow Accrual)
First Posted : January 10, 2005
Last Update Posted : February 27, 2017
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Sanofi-Synthelabo
Information provided by:
Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2007
  Actual Study Completion Date : March 2008